Bao Pharma appoints new joint company secretary and secures Listing Rules waiver

Bulletin Express07-08

Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) announced that Ms. Fong Christine Haiman will step down as joint company secretary, authorised representative and process agent with effect from 8 July 2026 due to other work arrangements. Following her resignation, Mr. Tsang Chun Ho has been appointed to all three roles on the same date, while Ms. Li Cui continues as the other joint company secretary.

Ms. Li, currently chief financial officer, board secretary and executive director, has held senior finance and governance roles since joining the company in December 2021. Mr. Tsang, a manager at Tricor Services Limited with over 12 years of company secretarial experience, is a Chartered Secretary and Chartered Governance Professional.

The Hong Kong Stock Exchange has granted Bao Pharma a waiver from strict compliance with Listing Rules 3.28 and 8.17 regarding Ms. Li’s eligibility as joint company secretary. The waiver runs from Mr. Tsang’s appointment on 8 July 2026 to 9 December 2028 and is conditional on: 1) Ms. Li being assisted by Mr. Tsang during the waiver period, and 2) automatic revocation if the company commits material breaches of the Listing Rules.

Before the waiver expires, Bao Pharma must demonstrate that Ms. Li has gained sufficient experience to fulfil the company secretary role independently. The board expressed gratitude to Ms. Fong for her contributions and welcomed Mr. Tsang to his new position.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1131855067?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-08 18:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131855067","market":"us","top_or_hot":-1,"title":"Bao Pharma appoints new joint company secretary and secures Listing Rules waiver","media":"Bulletin Express","content":"<p>Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) announced that Ms. Fong Christine Haiman will step down as joint company secretary, authorised representative and process agent with effect from 8 July 2026 due to other work arrangements. Following her resignation, Mr. Tsang Chun Ho has been appointed to all three roles on the same date, while Ms. Li Cui continues as the other joint company secretary.</p>\n<p>Ms. Li, currently chief financial officer, board secretary and executive director, has held senior finance and governance roles since joining the company in December 2021. Mr. Tsang, a manager at Tricor Services Limited with over 12 years of company secretarial experience, is a Chartered Secretary and Chartered Governance Professional.</p>\n<p>The Hong Kong Stock Exchange has granted Bao Pharma a waiver from strict compliance with Listing Rules 3.28 and 8.17 regarding Ms. Li’s eligibility as joint company secretary. The waiver runs from Mr. Tsang’s appointment on 8 July 2026 to 9 December 2028 and is conditional on:  \n1) Ms. Li being assisted by Mr. Tsang during the waiver period, and  \n2) automatic revocation if the company commits material breaches of the Listing Rules.</p>\n<p>Before the waiver expires, Bao Pharma must demonstrate that Ms. Li has gained sufficient experience to fulfil the company secretary role independently. The board expressed gratitude to Ms. Fong for her contributions and welcomed Mr. Tsang to his new position.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bao Pharma appoints new joint company secretary and secures Listing Rules waiver</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBao Pharma appoints new joint company secretary and secures Listing Rules waiver\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-08 18:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) announced that Ms. Fong Christine Haiman will step down as joint company secretary, authorised representative and process agent with effect from 8 July 2026 due to other work arrangements. Following her resignation, Mr. Tsang Chun Ho has been appointed to all three roles on the same date, while Ms. Li Cui continues as the other joint company secretary.</p>\n<p>Ms. Li, currently chief financial officer, board secretary and executive director, has held senior finance and governance roles since joining the company in December 2021. Mr. Tsang, a manager at Tricor Services Limited with over 12 years of company secretarial experience, is a Chartered Secretary and Chartered Governance Professional.</p>\n<p>The Hong Kong Stock Exchange has granted Bao Pharma a waiver from strict compliance with Listing Rules 3.28 and 8.17 regarding Ms. Li’s eligibility as joint company secretary. The waiver runs from Mr. Tsang’s appointment on 8 July 2026 to 9 December 2028 and is conditional on:  \n1) Ms. Li being assisted by Mr. Tsang during the waiver period, and  \n2) automatic revocation if the company commits material breaches of the Listing Rules.</p>\n<p>Before the waiver expires, Bao Pharma must demonstrate that Ms. Li has gained sufficient experience to fulfil the company secretary role independently. The board expressed gratitude to Ms. Fong for her contributions and welcomed Mr. Tsang to his new position.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02659","symbol_name":"宝济药业-B","start_time":0,"source_url":"","article_id":"1131855067","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131855067","pubTimestamp":1783504997,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) announced that Ms. Fong Christine Haiman will step down as joint company secretary, authorised representative and process agent with effect from 8...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02659":"宝济药业-B"},"translate_title":"宝药业委任新联席公司秘书并获得上市规则豁免","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1},"content_text":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) announced that Ms. Fong Christine Haiman will step down as joint company secretary, authorised representative and process agent with effect from 8 July 2026 due to other work arrangements. Following her resignation, Mr. Tsang Chun Ho has been appointed to all three roles on the same date, while Ms. Li Cui continues as the other joint company secretary.\nMs. Li, currently chief financial officer, board secretary and executive director, has held senior finance and governance roles since joining the company in December 2021. Mr. Tsang, a manager at Tricor Services Limited with over 12 years of company secretarial experience, is a Chartered Secretary and Chartered Governance Professional.\nThe Hong Kong Stock Exchange has granted Bao Pharma a waiver from strict compliance with Listing Rules 3.28 and 8.17 regarding Ms. Li’s eligibility as joint company secretary. The waiver runs from Mr. Tsang’s appointment on 8 July 2026 to 9 December 2028 and is conditional on:  \n1) Ms. Li being assisted by Mr. Tsang during the waiver period, and  \n2) automatic revocation if the company commits material breaches of the Listing Rules.\nBefore the waiver expires, Bao Pharma must demonstrate that Ms. Li has gained sufficient experience to fulfil the company secretary role independently. The board expressed gratitude to Ms. Fong for her contributions and welcomed Mr. Tsang to his new position.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1131855067","isCrawlerRequest":true}